Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge

Daily home monitoring of potassium, creatinine, and estimated plasma volume in heart failure post‐discharge

Abstract Aims Congestive status, serum potassium, and renal function are major determinants of outcomes as well as critical elements for adjusting drug therapy in heart failure (HF) patients. This study aimed at describing the daily variations in estimated plasma volume (ePV, a surrogate of congesti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Patrick Rossignol, Renaud Fay, Nicolas Girerd, Faiez Zannad
Format:	Article
Language:	English
Published:	Wiley 2020-06-01
Series:	ESC Heart Failure
Subjects:	Hypokalaemia Hyperkalaemia Estimated plasma volume Kidney function Heart failure with reduced ejection fraction Monitoring
Online Access:	https://doi.org/10.1002/ehf2.12642
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Efficacy of vericiguat in patients with chronic heart failure and reduced ejection fraction: a prospective observational study
by: Yinge Zhan, et al.
Published: (2025-02-01)

A case of thyrotoxic paralysis caused by consumption of Iodocaseine
by: Antonio Villa, et al.
Published: (2019-07-01)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
by: Seonhwa Lee, et al.
Published: (2020-06-01)

The Role of the Estimated Plasma Volume Variation in Assessing Decongestion in Patients with Acute Decompensated Heart Failure
by: Andreea-Maria Grigore, et al.
Published: (2025-01-01)

Prevalence, associated factors, management and outcomes of hypokalaemia in hospitalised patients at a South African tertiary centre
by: C Burton, et al.
Published: (2024-11-01)

Peripartum Cardiomyopathy: A Case Report
by: Ozlem Ece Basaran, et al.
Published: (2020-08-01)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
by: Daniela Tomasoni, et al.
Published: (2022-06-01)

Calculated plasma volume status in hemodialysis patients
by: Qiankun Zhang, et al.
Published: (2024-12-01)

Posterior reversible encephalopathy syndrome related to severe hypomagnesaemia
by: Martín Naya Rosato, et al.
Published: (2025-01-01)

Impact of Initial Heart Rate, Diastolic Pressure, and Pulse Pressure on Prognostic Outcomes in Heart Failure Patients with Mildly Reduced Ejection Fraction
by: Hu H, et al.
Published: (2025-01-01)

Characteristics and Outcomes of Heart Failure Outpatients with Improvement in Ejection Fraction in Qatar
by: Rasha Kaddoura, et al.
Published: (2024-07-01)

Clinical characteristics and outcomes in Asian patients with heart failure with mildly reduced ejection fraction
by: Julian Cheong Kiat Tay, et al.
Published: (2024-07-01)

Clinical study on the treatment of chronic heart failure with a novel D‐shant atrium shunt device
by: Xiaoke Shang, et al.
Published: (2022-06-01)

Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study
by: Ombretta Para, et al.
Published: (2025-02-01)

Sacubitril/valsartan on right ventricular-pulmonary artery coupling and albumin-bilirubin score in heart failure in Chinese patients with reduced ejection fraction
by: Yanan Shi, et al.
Published: (2025-01-01)

Spatial characterization of debris ejection from the interaction of a tightly focused PW-laser pulse with metal targets
by: I.-M. Vladisavlevici, et al.

Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01)

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction
by: Dae-Young Kim, et al.
Published: (2025-02-01)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
by: Rolf Wachter, et al.
Published: (2020-06-01)

Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
by: Xinye Li, et al.
Published: (2025-03-01)

Analysis of Factors Related to Early Left Ventricular Dysfunction in Hypertensive Patients with Preserved Ejection Fraction Using Speckle Tracking Echocardiography: A Cross-Sectional Study in Vietnam
by: Hoang M. Tran, et al.
Published: (2025-01-01)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
by: Anouk Achten, et al.
Published: (2025-04-01)

Effect of atrial high-rate episodes (AHREs) on functional status and quality of life (QoL) in heart failure—cardiac resynchronization therapy population
by: Lamyaa Elsayed Allam, et al.
Published: (2025-02-01)

Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure
by: Akihiro Shirakabe, et al.
Published: (2022-06-01)

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity
by: Bas M. van Dalen, et al.
Published: (2025-02-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Clinical characteristics and quality of life of patients with coronary heart disease before revascularization
by: Yu.A. Borkhalenko, et al.
Published: (2016-11-01)

Outcomes of Worsened Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Replacement
by: Hu Z, et al.
Published: (2025-01-01)

Micro failure analysis of adhesively bonded joints enhanced with natural cork particles: Impact of overlap length and particles volume fraction
by: Alireza Akhavan-Safar, et al.
Published: (2018-10-01)

Testing the Flux Rope Paradigm for Coronal Mass Ejections Using a Three-spacecraft Encounter Event
by: Brian E. Wood, et al.
Published: (2025-01-01)

Extracellular volume fraction and native T1 mapping in diabetic cardiomyopathy: a comprehensive meta-analysis
by: Ahmed Marey, et al.
Published: (2025-02-01)

The Effect Of Demographic Factors And Comorbidities On Ejection Fraction Outcome In Acute Myocardial Infarction Patients
by: Kausar Malik, et al.
Published: (2024-09-01)

Socioeconomic status and left ventricular ejection fraction decline in breast cancer survivors following receipt of doxorubicin (PREVENT WF-98213)
by: Arnethea L. Sutton, et al.
Published: (2025-02-01)

Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature
by: Navkaranbir S. Bajaj, et al.
Published: (2020-06-01)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01)

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction
by: Tomoyuki Hamada, et al.
Published: (2022-06-01)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Association between insulin resistance indices and outcomes in patients with heart failure with preserved ejection fraction
by: Weicheng Ni, et al.
Published: (2025-01-01)